The importance of new therapeutics in healthcare will continue to increase, which in turn will allow selected biotechnology activities to benefit handsomely. R, D, M fundamentals Despite my belief ...

Although biotech revenue and R&D spending continued to expand rapidly last year, profitability became a little more elusive. R&D as a share of revenue declined slightly from 34% the previous year ...